Dimensional Fund Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,428
| Closed | -$7.5K | – | 3350 |
|
|
2024
Q4 | $7.5K | Sell |
14,428
-58,976
| -80% | -$30.7K | ﹤0.01% | 3339 |
|
|
2024
Q3 | $238K | Buy |
73,404
+4
| +0% | +$13 | ﹤0.01% | 3143 |
|
|
2024
Q2 | $220K | Sell |
73,400
-420
| -0.6% | -$1.26K | ﹤0.01% | 3148 |
|
|
2024
Q1 | $343K | Hold |
73,820
| – | – | ﹤0.01% | 3112 |
|
|
2023
Q4 | $305K | Hold |
73,820
| – | – | ﹤0.01% | 3130 |
|
|
2023
Q3 | $221K | Sell |
73,820
-933
| -1% | -$2.8K | ﹤0.01% | 3200 |
|
|
2023
Q2 | $184K | Buy |
74,753
+19,185
| +35% | +$47.2K | ﹤0.01% | 3247 |
|
|
2023
Q1 | $126K | Sell |
55,568
-5,065
| -8% | -$11.4K | ﹤0.01% | 3276 |
|
|
2022
Q4 | $211 | Sell |
60,633
-138,267
| -70% | -$481 | ﹤0.01% | 3217 |
|
|
2022
Q3 | $7.36M | Sell |
198,900
-2,707
| -1% | -$100K | ﹤0.01% | 2283 |
|
|
2022
Q2 | $3.83M | Buy |
201,607
+80,860
| +67% | +$1.54M | ﹤0.01% | 2527 |
|
|
2022
Q1 | $3.26M | Buy |
120,747
+55,685
| +86% | +$1.5M | ﹤0.01% | 2673 |
|
|
2021
Q4 | $1.47M | Buy |
65,062
+11,858
| +22% | +$267K | ﹤0.01% | 2933 |
|
|
2021
Q3 | $1.39M | Buy |
53,204
+40,239
| +310% | +$1.05M | ﹤0.01% | 2956 |
|
|
2021
Q2 | $415K | Buy |
+12,965
| New | +$415K | ﹤0.01% | 3201 |
|